Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Eucure (Beijing) Biopharma Co., Ltd
Scientific Title
A Multi-center, Open-label Phase II Study to Evaluate the Safety and Efficacy of YH003 in Combination With Toripalimab (Anti-PD-1 mAb) in Patients With Unresectable/Metastatic Melanoma and Pancreatic Ductal Adenocarcinoma (PDAC)